Intensity of pain. Other acute postprocedural pain
Conditions
Interventions
Intervention 1: Intervention group: 100 micrograms of morphine (manufactured by Abu Rehan Company) with 2.5 cc of bupivacaine 0.5% (manufactured by Abu Rehan Pharmaceuticals) plus a low dose of 2 micr
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women aged 18 to 50 years Elective cesarean birth for first and second gravid
Exclusion criteria
Exclusion criteria: Patient refusal to participate in the study Failure to create the required level of anesthesia and turning spinal anesthesia into general History of drug addiction History of allergy to any of the drugs used in this research History of known cardiovascular, liver, kidney disease and blood coagulation problems and asthma Scoliosis or kyphosis or morbid obesity Height less than 130 cm and BMI greater than 35 Ketamine or narcotic injection to treat shivering in the second line
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of patients' pain. Timepoint: In hours 2, 4, 8, 12 after surgery. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation score. Timepoint: In hours 2, 4, 8, 12 after surgery. Method of measurement: Reverse Observer Assessment Scale of Consciousness/Sedation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlieh Zamani Kiasari
Iran University of Medical Sciences
Outcome results
None listed